Applicant, as named in the Orange Book

Ipsen Pharma

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis

None.

Somatuline Depot · Generic approved · ANDA 218217, AmnealApproved 18 Sep 2026Detected 25 Oct 2026

Products without listed protection (1)

Drug	Ingredient	Earliest generic entry	Basis
Somatuline Depot NDA 022074 · 3 strengths lanreotide acetate	lanreotide acetate	open now no listed protection	no listed protection